Vimarsana
Biggest News Aggregation in the World

Auxiliary Request News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Auxiliary Request. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Auxiliary Request Today - Breaking & Trending Today

Review of EPO Software Decisions in 2021 - Vimarsana News

Review of EPO Software Decisions in 2021

In 2021, reporting of the case law of the EPO Boards of Appeal in the field of IT & computer-implemented inventions has been dominated but two…

The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I | Rothwell, Figg, Ernst & Manbeck, P.C. - Vimarsana News

The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I | Rothwell, Figg, Ernst & Manbeck, P.C.

To embed, copy and paste the code into your website or blog: Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the United States Food & Drug Administration (FDA) granted emergency regulatory approval for two COVID-19 vaccines produced by Moderna and BioNTech (with Pfizer), making these groups the first to ever enter the commercial market with mRNA-based therapies. This little-known and never-before-approved mRNA technology has since been widely administered and represents a primary weapon being used to defeat t...